Gayer Charles K
Chief Commercial Officer at BCRX
- Sold, on record
- $66k
- Dollars the filings state
- Form 4 sales
- 1
- Latest Dec 15, 2022
- Form 144 notices
- 0
- Proposed sales
- Quarters with a sale
- 0 of the last 8
- No sale in two years
- Companies
- 1
- Filed as an executive or holder
Companies
- BCRXBIOCRYST PHARMACEUTICALS INCChief Commercial Officer
Sales by reason
0
Routine
1
Plan not stated
0
No plan
0
Unusual
Form 4 sales per year, every sale on record.
Timeline
- Dec 15, 2022Plan not stated
Sold 2.8% of their holdings
$66k6,100 shares at $10.90
1 of 1
Every transaction
| Traded | Filed | Stock | Role | What | Amount | Price | Value | Held after | Source |
|---|---|---|---|---|---|---|---|---|---|
| Dec 22, 2025 | Dec 23, 2025 | BCRX | President and CCO | Exercised or settledEmp. Stock Option (Right to Buy) | 74,233 | 0 | SEC | ||
| Dec 22, 2025 | Dec 23, 2025 | BCRX | President and CCO | Exercised options | 74,233 | $5.01 | $372k | 952,583 | SEC |
| Dec 19, 2025 | Dec 23, 2025 | BCRX | President and CCO | Withheld for tax | 11,477 | $7.41 | $85k | 878,350 | SEC |
| Dec 17, 2025 | Dec 19, 2025 | BCRX | President and CCO | AwardedEmp. Stock Option (Right to Buy) | 986,950 | 986,950 | SEC | ||
| Dec 17, 2025 | Dec 19, 2025 | BCRX | President and CCO | Awarded | 471,000 | 889,827 | SEC | ||
| Dec 12, 2025 | Dec 16, 2025 | BCRX | President and CCO | Withheld for tax | 8,181 | $7.57 | $62k | 418,827 | SEC |
| Dec 19, 2024 | Dec 23, 2024 | BCRX | Chief Commercial Officer | Withheld for tax | 2,461 | $7.39 | $18k | 423,546 | SEC |
| Dec 19, 2024 | Dec 23, 2024 | BCRX | Chief Commercial Officer | AwardedEmp. Stock Option (Right to Buy) | 260,950 | 260,950 | SEC | ||
| Dec 19, 2024 | Dec 23, 2024 | BCRX | Chief Commercial Officer | Awarded | 125,950 | 426,007 | SEC | ||
| Dec 14, 2024 | Dec 17, 2024 | BCRX | Chief Commercial Officer | Withheld for tax | 8,251 | $7.53 | $62k | 300,057 | SEC |
| May 13, 2024 | May 15, 2024 | BCRX | Chief Commercial Officer | Bought | 30,000 | $5.47 | $164k | 307,533 | SEC |
| Dec 19, 2023 | Dec 20, 2023 | BCRX | Chief Commercial Officer | Withheld for tax | 2,482 | $6.05 | $15k | 274,533 | SEC |
| Dec 14, 2023 | Dec 18, 2023 | BCRX | Chief Commercial Officer | Withheld for tax | 5,840 | $6.43 | $38k | 277,015 | SEC |
| Dec 14, 2023 | Dec 18, 2023 | BCRX | Chief Commercial Officer | AwardedEmp. Stock Option (Right to Buy) | 158,500 | 158,500 | SEC | ||
| Dec 14, 2023 | Dec 18, 2023 | BCRX | Chief Commercial Officer | Awarded | 34,000 | 282,855 | SEC | ||
| Dec 19, 2022 | Dec 21, 2022 | BCRX | Chief Commercial Officer | AwardedEmp. Stock Option (Right to Buy) | 158,500 | 158,500 | SEC | ||
| Dec 19, 2022 | Dec 21, 2022 | BCRX | Chief Commercial Officer | Awarded | 34,000 | 245,610 | SEC | ||
| Dec 15, 2022 | Dec 19, 2022 | BCRX | Chief Commercial Officer | Sold | 6,100 | $10.90 | $66k | 211,610 | SEC |
| Dec 14, 2021 | Dec 16, 2021 | BCRX | Chief Commercial Officer | AwardedEmp. Stock Option (Right to Buy) | 164,000 | 164,000 | SEC | ||
| Dec 14, 2021 | Dec 16, 2021 | BCRX | Chief Commercial Officer | Awarded | 125,000 | 261,556 | SEC | ||
| Dec 15, 2020 | Dec 17, 2020 | BCRX | Vice President and CCO | AwardedEmp. Stock Option (Right to Buy) | 190,000 | 190,000 | SEC |